Publication | Open Access
Noncovalent active site interactions enhance the affinity and control the binding order of reversible inhibitors of the cAMP-dependent protein kinase.
11
Citations
26
References
1990
Year
Molecular BiologyPharmacotherapyMolecular PharmacologyAmide-capped PeptidesCell SignalingInhibitory ActivityCamp-dependent Protein KinaseBiochemistryG Protein-coupled ReceptorBiochemical InteractionBiomolecular InteractionNon-peptide LigandPharmacologyReversible InhibitorsBovine Cardiac MuscleProtein PhosphorylationMolecular DockingSignal TransductionNatural SciencesThrough-space IsostereMedicineDrug Discovery
The peptides, Leu-Arg-Arg-Ala-Ala-Leu-Gly-NH2, Leu-Arg-Arg-Gln-Ala-Leu-Gly-NH2, and Leu-Arg-Arg-Asn-Ala-Leu-Gly-NH2, serve as active site-directed inhibitors of the cAMP-dependent protein kinase from bovine cardiac muscle. The Asn-containing peptide is a 10-fold more potent inhibitor than its Ala- and Gln-containing counterparts. All three peptides are linear competitive inhibitors versus a peptide-based substrate and uncompetitive inhibitors versus MgATP. The enhanced inhibitory potency of the Asn-peptide, in conjunction with the observed loss of ATP-ase activity of the enzyme in the presence of the inhibitor, suggests that asparagine may serve as a through-space isostere of serine. The uncompetitive inhibition pattern displayed by amide-capped peptides versus MgATP indicates that these species bind in an ordered fashion to the cAMP-dependent protein kinase, with MgATP binding first.
| Year | Citations | |
|---|---|---|
Page 1
Page 1